News

The Feinstein Institutes for Medical Research announced the launch a new research program and the first clinical trial to reduce cardiovascular disease in the Black community and determine the best behavioral interventions to lower cardiovascular disease (CVD).

A research team from Synapsy has shown that the severity of the clinical symptoms of schizophrenia is strongly linked to blood biomarkers related to the deregulation of neuronal mitochondria.

Our brain is extremely complex, performing countless complicated processes that allow us to think, move and feel. This is only possible because of the enormous diversity of cell types in the brain. Researchers investigated how this diversity arises.

In a new paper published in the Journal of Biological Chemistry, researchers describe a breakthrough using CRISPR-Cas9, a tool that has transformed molecular biological research, but whose use in the study of adipose tissue had been elusive.

A new study has found collegiate football athletes with a decade or more of experience with the sport have related abnormalities in inflammation, energy production and coordination that are apparent before the football season and across the season.

Multiple changes in brain cells during the first month of embryonic development may contribute to schizophrenia later in life, according to a new study.

Researchers describe a link between dwindling sea ice and worsening wildfires in the western United States.

In a paper published in Science, researchers at the UC Santa Cruz Genomics Institute have introduced a new tool, called Giraffe, that can efficiently map new genome sequences to a “pangenome” representing many diverse human genome sequences.

Breakthrough infections greatly enhance the immune response to variants of the virus that causes COVID-19, according to a newly published study.

The global scientific and medical research community should focus on better understanding coronavirus disease pathogenesis in laboratory animal models and people, and apply this knowledge to the development of long-lasting, broadly protective coronavirus vaccines